| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
91,847 |
65,282 |
$3.53M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
34,130 |
17,127 |
$2.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
45,941 |
35,733 |
$1.30M |
| J9271 |
Injection, pembrolizumab, 1 mg |
170 |
127 |
$997K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
168,785 |
107,087 |
$711K |
| 99215 |
Prolong outpt/office vis |
5,305 |
3,795 |
$358K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
6,625 |
1,907 |
$268K |
| 96367 |
|
10,928 |
5,872 |
$244K |
| 36415 |
Collection of venous blood by venipuncture |
138,816 |
90,227 |
$231K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
6,290 |
3,476 |
$224K |
| 99223 |
Prolong inpt eval add15 m |
2,079 |
1,948 |
$217K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
5,820 |
3,244 |
$136K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,933 |
8,127 |
$124K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,679 |
4,402 |
$119K |
| 80053 |
Comprehensive metabolic panel |
34,861 |
23,872 |
$117K |
| J0185 |
Injection, aprepitant, 1 mg |
951 |
596 |
$116K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,298 |
1,255 |
$112K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
241 |
137 |
$84K |
| J1437 |
Injection, ferric derisomaltose, 10 mg |
148 |
141 |
$84K |
| 96417 |
|
2,760 |
1,602 |
$83K |
| Q5126 |
Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg |
47 |
24 |
$70K |
| J0897 |
Injection, denosumab, 1 mg |
80 |
64 |
$67K |
| J1453 |
Injection, fosaprepitant, 1 mg |
991 |
499 |
$66K |
| J1756 |
Injection, iron sucrose, 1 mg |
2,433 |
1,076 |
$63K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
38 |
24 |
$53K |
| 82728 |
|
8,328 |
6,631 |
$32K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
467 |
453 |
$27K |
| 96523 |
|
1,573 |
1,233 |
$22K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
215 |
146 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,898 |
3,031 |
$20K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
720 |
221 |
$20K |
| 99205 |
Prolong outpt/office vis |
175 |
145 |
$17K |
| 96415 |
|
1,131 |
681 |
$16K |
| 82378 |
|
2,910 |
2,202 |
$15K |
| 82607 |
|
3,778 |
3,036 |
$14K |
| 84466 |
|
4,091 |
3,306 |
$14K |
| 96411 |
|
388 |
234 |
$12K |
| 83540 |
|
6,762 |
5,433 |
$11K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
10,914 |
5,574 |
$10K |
| 96416 |
|
131 |
73 |
$10K |
| 83735 |
|
4,683 |
2,649 |
$9K |
| J9267 |
Injection, paclitaxel, 1 mg |
219 |
83 |
$9K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
330 |
186 |
$8K |
| 86300 |
|
2,019 |
1,449 |
$8K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,195 |
1,628 |
$7K |
| 83550 |
|
3,639 |
2,985 |
$7K |
| 82784 |
|
973 |
846 |
$7K |
| J9190 |
Injection, fluorouracil, 500 mg |
523 |
292 |
$7K |
| 83615 |
|
3,643 |
2,741 |
$6K |
| 84165 |
|
2,142 |
1,645 |
$6K |
| 86334 |
|
1,318 |
1,033 |
$5K |
| 96368 |
|
503 |
295 |
$5K |
| 82746 |
|
1,534 |
1,269 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
599 |
458 |
$5K |
| 99255 |
|
39 |
38 |
$5K |
| 83883 |
|
1,178 |
1,039 |
$4K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
87 |
47 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
133 |
120 |
$4K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
206 |
80 |
$3K |
| J1750 |
Injection, iron dextran, 50 mg |
66 |
26 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
50 |
43 |
$3K |
| 99253 |
|
28 |
27 |
$2K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
229 |
139 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
38 |
25 |
$2K |
| 99221 |
|
29 |
27 |
$1K |
| 88185 |
|
17 |
12 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
33 |
12 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
228 |
194 |
$1K |
| 86304 |
|
129 |
91 |
$1K |
| 99254 |
|
15 |
13 |
$1K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
30 |
27 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,776 |
897 |
$967.28 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
32 |
29 |
$827.86 |
| 51798 |
|
334 |
283 |
$668.65 |
| 99442 |
|
49 |
41 |
$582.20 |
| J9045 |
Injection, carboplatin, 50 mg |
42 |
24 |
$535.11 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
487 |
235 |
$516.79 |
| 86301 |
|
58 |
41 |
$510.28 |
| 81002 |
|
824 |
657 |
$433.81 |
| 84153 |
|
128 |
95 |
$402.09 |
| 84439 |
|
100 |
63 |
$339.51 |
| G0452 |
Molecular pathology procedure; physician interpretation and report |
45 |
30 |
$297.34 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
74 |
52 |
$180.62 |
| 84100 |
|
145 |
94 |
$169.50 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
42 |
41 |
$164.84 |
| 88184 |
|
17 |
12 |
$96.44 |
| 83010 |
|
16 |
12 |
$79.68 |
| 88189 |
|
18 |
15 |
$71.01 |
| J3490 |
Unclassified drugs |
127 |
49 |
$63.36 |
| 82962 |
|
38 |
13 |
$21.85 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
16 |
12 |
$19.33 |
| G9678 |
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement |
1,723 |
1,625 |
$0.00 |
| M0010 |
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services |
106 |
106 |
$0.00 |